Author

Lukas Wettstein

Universität UlmORCID 0000-0002-8182-9309Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Annelies StevaertiD· 1 shared Armando RodrígueziD· 1 shared Dan AlbersiD· 1 shared Daniel SauteriD· 1 shared Eberhard BarthiD· 1 shared Elsa Sánchez‐GarcíaiD· 1 shared Emilia Schmierer· 1 shared Fabian ZechiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Annelies StevaertORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Trypstatin as a Novel TMPRSS2 Inhibitor with Broad-Spectrum 1 Efficacy Against Corona and Influenza Viruses

Jan Lawrenz, Lukas Wettstein, Armando Rodríguez, Rayhane Nchioua, Pascal von Maltitz, Dan Albers, Fabian Zech, Julie Vandeput, Lieve M. J. Naesens, Giorgio Fois, Veronika Neubauer, Nico Preising, Emilia Schmierer, Yasser Almeida‐Hernández, Moritz Petersen, , Jan Münch

This paper identifies Trypstatin, a Kunitz-type protease inhibitor that inhibits TMPRSS2 and related proteases, showing broad-spectrum antiviral activity against SARS-CoV-2, influenza, and other respiratory viruses.

Advanced Science · May 14, 2025Peer-reviewedMicrobiology